SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 52 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,000 | -62.5% | 11,235 | -43.1% | 0.00% | – |
| Q1 2020 | $8,000 | -74.2% | 19,735 | -78.2% | 0.00% | – |
| Q4 2019 | $31,000 | +138.5% | 90,735 | +386.9% | 0.00% | – |
| Q3 2019 | $13,000 | -27.8% | 18,635 | -24.0% | 0.00% | – |
| Q2 2019 | $18,000 | -10.0% | 24,535 | +51.1% | 0.00% | – |
| Q1 2019 | $20,000 | +185.7% | 16,235 | -4.1% | 0.00% | – |
| Q4 2018 | $7,000 | -82.5% | 16,935 | -15.6% | 0.00% | – |
| Q3 2018 | $40,000 | -2.4% | 20,069 | +3.1% | 0.00% | – |
| Q2 2018 | $41,000 | – | 19,469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|